Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

ACADIA Pharmaceuticals Inc (NASDAQ: ACAD)

 
ACAD Technical Analysis
4
As on 9th Jun 2023 ACAD SHARE Price closed @ 24.72 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 19.20 & Buy for SHORT-TERM with Stoploss of 24.01 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ACADSHARE Price

Open 25.02 Change Price %
High 25.23 1 Day -0.37 -1.47
Low 24.64 1 Week 1.22 5.19
Close 24.72 1 Month 4.22 20.59
Volume 691400 1 Year 3.27 15.24
52 Week High 27.50 | 52 Week Low 13.01
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
ACAD
Daily Charts		 ACAD
Intraday Charts		 Whats New @
Bazaartrend		 ACAD
Free Analysis
 
ACAD Important Levels Intraday
RESISTANCE25.86
RESISTANCE25.49
RESISTANCE25.27
RESISTANCE25.04
SUPPORT24.40
SUPPORT24.17
SUPPORT23.95
SUPPORT23.58
 
ACAD Forecast April 2024
Share
4th UP Forecast38.34
3rd UP Forecast33.97
2nd UP Forecast31.27
1st UP Forecast28.57
1st DOWN Forecast20.87
2nd DOWN Forecast18.17
3rd DOWN Forecast15.47
4th DOWN Forecast11.1
 
ACAD Weekly Forecast
4th UP Forecast28.86
3rd UP Forecast27.53
2nd UP Forecast26.71
1st UP Forecast25.89
1st DOWN Forecast23.55
2nd DOWN Forecast22.73
3rd DOWN Forecast21.91
4th DOWN Forecast20.58
 
ACAD Forecast2024
4th UP Forecast55.21
3rd UP Forecast45.43
2nd UP Forecast39.39
1st UP Forecast33.34
1st DOWN Forecast16.1
2nd DOWN Forecast10.05
3rd DOWN Forecast4.01
4th DOWN Forecast-5.77
 
 
ACAD Other Details
Segment EQ
Market Capital 2922096384.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ACAD Address
ACAD
 
ACAD Latest News
 
Your Comments and Response on ACADIA Pharmaceuticals Inc
 
ACAD Business Profile
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; Trofinetide, a novel synthetic analog for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor for treating cognition and schizophrenia. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California. Address: 12830 El Camino Real, San Diego, CA, United States, 92130
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service